Beaphar One Dose Wormer for Dogs, 500 mg Film Coated Tablets

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: VMD (Veterinary Medicines Directorate)

Ակտիվ բաղադրիչ:

Nitroscanate

Հասանելի է:

Elanco Europe Ltd

ATC կոդը:

QP52AX01

INN (Միջազգային անվանումը):

Nitroscanate

Դեղագործական ձեւ:

Film-coated tablet

Ռեկվիզորի տեսակը:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Թերապեւտիկ խումբ:

Dogs

Թերապեւտիկ տարածք:

Anthelmintic

Լիազորման կարգավիճակը:

Expired

Հաստատման ամսաթիվը:

2000-06-30

Ապրանքի հատկությունները

Revised: November 2018
AN: 00829/2018
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar One Dose Wormer for Dogs, 500 mg film coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
500
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Yellowish-white to light beige round, film coated tablet, with
‘BCB’ imprinted on
one side and ‘CGV’ on the other.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for use in dogs. It is highly effective
in a single
dose against common canine nematodes and cestodes in the UK: _Toxocara
_
_canis, Toxascaris leonina, Ancylostoma caninum, Uncinaria
stenocephala, Taenia _
_ovis, Taenia hydatigena, Taenia pisiformis _and_ Dipylidium caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus _
_granulosus._
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Do not repeat treatment if vomiting occurs shortly after dosing.
Revised: November 2018
AN: 00829/2018
Page 2 of 4
ii.
Special precautions to be taken by the person administering the
medicinal
product to animals
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting.
Do not repeat treatment if vomiting occurs shortly after dosing.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing bitches should be
treated at the
same time and as frequently as puppies up to 12 weeks of age (i.e. 2,
4, 6, 8,
12 weeks).
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral administration only. For the routine treatment of adult dogs